Zai Lab Ltd
ZLAB
47 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.42 | $970.9K | 964,161(D) | View → |
| Mar 9, 2026 | Mar 9 6:12 PM | Du Ying | Proposed Sale | 50,000 | $19.21 | $960.5K | — | View → |
| Mar 5, 2026 | Mar 6 9:26 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 15,569 | $19.06 | $296.7K | 3,517(D) | View → |
| Mar 5, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.22 | $961.1K | 964,161(D) | View → |
| Mar 4, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.16 | $958.2K | 964,161(D) | View → |
| Mar 6, 2026 | Mar 6 3:57 PM | Du Ying | Proposed Sale | 50,000 | $19.18 | $959.0K | — | View → |
| Mar 3, 2026 | Mar 5 9:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Sale | 10,000 | $17.38 | $173.8K | 42,391(D) | View → |
| Mar 5, 2026 | Mar 5 6:20 PM | Edmondson Frazor Titus III | Proposed Sale | 15,569 | $19.06 | $296.7K | — | View → |
| Mar 5, 2026 | Mar 5 6:12 PM | Du Ying | Proposed Sale | 50,000 | $19.06 | $953.0K | — | View → |
| Mar 4, 2026 | Mar 4 4:21 PM | Du Ying | Proposed Sale | 50,000 | $18.28 | $914.0K | — | View → |
| Mar 3, 2026 | Mar 3 5:38 PM | Amado Rafael | Proposed Sale | 10,000 | $17.38 | $173.8K | — | View → |
| Dec 31, 2025 | Dec 31 8:29 PM | Amado Rafael | Proposed Sale | 10,787 | $17.43 | $188.0K | — | View → |
| Dec 16, 2025 | Dec 16 3:47 PM | Edmondson Frazor Titus III | Proposed Sale | 8,651 | $17.14 | $148.3K | — | View → |
| Nov 21, 2025 | Nov 21 2:43 PM | Edmondson Frazor Titus III | Proposed Sale | 14,328 | $19.78 | $283.4K | — | View → |
| Nov 3, 2025 | Nov 3 8:31 PM | Chen Yajing | Proposed Sale | 240 | $26.83 | $6.4K | — | View → |
| Oct 2, 2025 | Oct 2 7:36 PM | Chen Yajing | Proposed Sale | 456 | $34.25 | $15.6K | — | View → |
| Aug 18, 2025 | Aug 18 7:15 PM | Edmondson Frazor Titus III | Proposed Sale | 1,883 | $36.24 | $68.2K | — | View → |
| Aug 18, 2025 | Aug 18 7:14 PM | Smiley Joshua L | Proposed Sale | 6,641 | $36.24 | $240.6K | — | View → |
| Aug 15, 2025 | Aug 15 7:21 PM | Chen Yajing | Proposed Sale | 610 | $35.27 | $21.5K | — | View → |
| Aug 15, 2025 | Aug 15 2:24 PM | Chen Yajing | Proposed Sale | 828 | $35.53 | $29.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Apr 3 9:58 PM | Frazor Titus Edmondson IIIChief Legal Officer | Grant/Award | 11,924 | — | 11,924(D) | View → |
| Apr 2, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 6,750 | — | 13,500(D) | View → |
| Apr 1, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 14,200 | — | 0(D) | View → |
| Mar 4, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Grant/Award | 25,579 | — | 25,579(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Option Exercise | 2,500 | — | 2,500(D) | View → |
| Apr 1, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Option Exercise | 15,258 | — | 27,516(D) | View → |
| Mar 4, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Grant/Award | 11,924 | — | 11,924(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 5,391 | — | 5,391(D) | View → |
| Apr 1, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 19,523 | — | 39,046(D) | View → |
| Mar 4, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Grant/Award | 14,905 | — | 14,905(D) | View → |
| Mar 12, 2026 | Mar 16 8:09 PM | Joshua L SmileyPresident and Chief Operating Officer | Option Exercise | 6,388 | — | 19,165(D) | View → |
| Mar 4, 2026 | Mar 16 8:09 PM | Joshua L SmileyPresident and Chief Operating Officer | Grant/Award | 137,733 | $19.27 | 33,783(D) | View → |
| Mar 12, 2026 | Mar 16 8:08 PM | Frazor Titus Edmondson IIIChief Legal Officer | Option Exercise | 4,258 | — | 12,777(D) | View → |
| Mar 4, 2026 | Mar 16 8:08 PM | Frazor Titus Edmondson IIIChief Legal Officer | Grant/Award | 110,187 | $19.27 | 27,027(D) | View → |
| Mar 12, 2026 | Mar 16 8:08 PM | Yajing ChenChief Financial Officer | Option Exercise | 4,258 | — | 12,777(D) | View → |
| Mar 4, 2026 | Mar 16 8:08 PM | Yajing ChenChief Financial Officer | Grant/Award | 110,187 | $19.27 | 27,027(D) | View → |
| Mar 12, 2026 | Mar 16 8:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 5,323 | — | 15,971(D) | View → |
| Mar 4, 2026 | Mar 16 8:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Grant/Award | 137,733 | $19.27 | 33,783(D) | View → |
| Mar 11, 2026 | Mar 16 8:06 PM | Ying DuDirector, Chairperson & CEO | Grant/Award | 385,849 | $19.34 | 32,419(D) | View → |
| Mar 10, 2026 | Mar 12 8:12 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 263,747 | $1.74 | 7,965(D) | View → |